J3373 HCPCS Level II code: Injection, vancomycin hydrochloride, 10 mg
J3373 is the HCPCS code for “Injection, vancomycin hydrochloride, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3373Injection, vancomycin hydrochloride, 10 mg
Short description: Inj, vancomycin hcl, 10 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3373 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2025
Where J3373 sits
- 1J codesDrugs administered other than orally
- 2Active code J3373Injection, vancomycin hydrochloride, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3373 mean?
J3373 is the HCPCS code for “Injection, vancomycin hydrochloride, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3373?
CMS lists J3373’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3373
All J codesJ3360Injection, diazepam, up to 5 mgJ3364Injection, urokinase, 5000 iu vialJ3365Injection, iv, urokinase, 250,000 i.u. vialJ3370Injection, vancomycin hcl, 500 mgJ3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgJ3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgJ3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mgJ3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mgJ3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mgJ3379Injection, valproate sodium, 5 mgJ3380Injection, vedolizumab, intravenous, 1 mgJ3385Injection, velaglucerase alfa, 100 units